Fresh analysis suggests that people who discontinue blockbuster GLP-1 drugs like Wegovy and Mounjaro may regain shed pounds much more quickly than those who stop traditional diet and exercise regimens.
Published data in a major medical journal demonstrates that while obese people often shed substantial amounts of their body weight while undergoing treatment, the mass comes back at an estimated rate of 0.8 kg per month after stopping.
"Individuals purchasing these drugs should be cognizant of the danger of rapid weight regain when the treatment is stopped," cautioned researcher Dr. Susan Jebb.
That rate of recovery implies a reversion to starting mass within about 18 months.
Comparing Approaches
The analysis, which examined 37 of studies involving over 9,000 of participants, contrasted the results of GLP-1 agonists with other pills.
The team emphasize that individuals who lose weight through diet and exercise typically have a more gradual creep back—around 0.1 kg a month—after stopping.
Understanding the Rapid Regain
Nutrition scientists suggest the way of the jabs accounts for the heightened regain.
GLP-1 drugs mimic a body's own chemical called GLP-1, which moderates feelings of fullness.
"Artificially providing the hormone levels several times higher than the body's typical production may cause the body to produce less of its endogenous hormone, and may also diminish sensitivity to its actions," noted Dr. Adam Collins, a dietetics expert.
"Discontinuation of this hormone supplement leads to hunger is uncontrolled, making excessive eating a significant risk."
A Chronic Issue?
The NHS suggest the injections for people with obesity-related medical conditions, alongside recommended diet and exercise modifications.
A number of clinicians contend that, due to the high risk of weight regain, the therapy is often life-long.
This view is reinforced by drug manufacturers, who say that the results "emphasize the chronic character of excess weight," akin to managing conditions like high blood pressure.
Patient Accounts
Individuals who have stopped the medication report a intense resurgence of cravings.
"It was like a trigger activating and you become ravenous," recalled one woman.
The struggle is compounded if patients have not adopted lasting lifestyle or habit changes during treatment.
Growing Adoption
Figures suggest that millions of adults in the UK have used weight-loss jabs in the last 12 months, with desire continuing to grow.
- Use is more common among females than men.
- The 40s and 50s age group shows the highest usage rates.
- A large proportion obtain the medications through private prescriptions rather than public health services.
Finally, experts stress that while GLP-1 drugs are powerful agents for weight loss, they are not a magic solution and lasting health benefits relies on integrated lifestyle changes.